Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 29Recruiting 9Unknown 7Active not recruiting 7Terminated 4Withdrawn 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 4Breast 4Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 1131Neoplasms 986Carcinoma, Non-Small-Cell Lung 902Prostatic Neoplasms 595Neoplasm Metastasis 529Leukemia, Myeloid, Acute 514Colorectal Neoplasms 492Lung Neoplasms 489Melanoma 488Multiple Myeloma 478Pancreatic Neoplasms 387Lymphoma 370Ovarian Neoplasms 368Recurrence 365Lymphoma, Non-Hodgkin 348Leukemia 340Leukemia, Lymphocytic, Chronic, B-Cell 322Precursor Cell Lymphoblastic Leukemia-Lymphoma 291Head and Neck Neoplasms 276Carcinoma, Renal Cell 276Brain Neoplasms 276Carcinoma, Hepatocellular 261Glioblastoma 250Lymphoma, Large B-Cell, Diffuse 244Myelodysplastic Syndromes 243Squamous Cell Carcinoma of Head and Neck 241Lymphoma, Follicular 236Colonic Neoplasms 214Stomach Neoplasms 200Rectal Neoplasms 190

Interventions

prexasertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Hereditary Breast and Ovarian Cancer Syndrome × Clear all
NCT04508764 2024-04-16

Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome

Washington University School of Medicine

Phase NA Terminated
96 enrolled
BreastGastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Hereditary Breast and Ovarian Cancer Syndrome

NCT04668521 2023-12-26

OVA360

Aspira Women's Health

Terminated
215 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT02203513 2022-09-10

A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
111 enrolled 15 charts
BreastGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT02705924 2021-11-30

Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk

Centre Jean Perrin

Phase NA Terminated
32 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡